Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Denise Grieshober"'
Autor:
Corinne Hübers, Ashik Ahmed Abdul Pari, Denise Grieshober, Martin Petkov, Alexander Schmidt, Tatjana Messmer, Christian Moritz Heyer, Sebastian Schölch, Stephanie S. Kapel, Nicolas Gengenbacher, Mahak Singhal, Benjamin Schieb, Claudine Fricke, Rainer Will, Kim Remans, Jochen Sven Utikal, Christoph Reissfelder, Matthias Schlesner, Kairbaan M. Hodivala-Dilke, Sander Kersten, Sergij Goerdt, Hellmut G. Augustin, Moritz Felcht
Publikováno v:
The Journal of experimental medicine 220 (2023) 1
The Journal of experimental medicine, 220(1)
The Journal of experimental medicine, 220(1)
Primary tumors and distant site metastases form a bidirectionally communicating system. Yet, the molecular mechanisms of this crosstalk are poorly understood. Here, we identified the proteolytically cleaved fragments of angiopoietin-like 4 (ANGPTL4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d6557506897f756b5b1d14126c62176
https://research.wur.nl/en/publications/primary-tumor-derived-systemic-nangptl4-inhibits-metastasis
https://research.wur.nl/en/publications/primary-tumor-derived-systemic-nangptl4-inhibits-metastasis
Publikováno v:
Physiology. 38:000-000
Proliferating cancer cells secrete a multitude of factors impacting metabolism, interorgan communication, and tumor progression. The distribution of tumor-derived factors to distant organs occurs via the circulation, which provides an extensive react
Autor:
Michelina Plateroti, Mi Young Son, Mitzli X. Velasco, Talia Delambre, Mirella Baroni, Luiz O. F. Penalva, Patrícia R. Araújo, Xiufen Lei, Mei Qiao, Caihong Yi, Adam Kosti, Paul Hasty, Denise Grieshober, Marco A. R. Ferreira, Saket Choudhary, Suzanne S. Burns
Publikováno v:
Cancers, Vol 13, Iss 1494, p 1494 (2021)
Cancers
Cancers, 2021, 13 (7), pp.1494. ⟨10.3390/cancers13071494⟩
Volume 13
Issue 7
Cancers
Cancers, 2021, 13 (7), pp.1494. ⟨10.3390/cancers13071494⟩
Volume 13
Issue 7
Simple Summary Glioblastoma (GBM) is one of the most aggressive tumor types with no effective treatment options. To create new routes for therapy, it is necessary to continue mapping new pathways contributing to gliomagenesis. In this regard, there i